Archive | Innovator’s Pitch Challenge RSS feed for this section

Winners of Digital RESI June 2021 Innovator’s Pitch Challenge (IPC)

17 Jun

By Claire Jeong, Chief Conference Officer, Vice President of Investor Research, Asia BD, LSN

claire

Digital Redefining Early Stage Investments (RESI) June ended on a high note last week, again providing a valuable platform for early-stage life science companies and investors/strategic partners to connect and start dialogue.

This RESI also featured the largest number of Innovator’s Pitch Challenge companies, with almost fifty companies participating. Each company was assigned to one of ten live Q&A sessions featuring investors and industry partners, based on sector/technology.

Attendees voted for their favorite companies throughout the three days of the conference. Check out the winners below!

1st Place – Throne Biotechnologies

Throne is an American therapeutics company aimed at commercializing a novel stem cell technology that can fundamentally reverse diabetes, alopecia areata and other autoimmune diseases through immune education. The patented technology is recognized as the leading “practical cure project” for type 1 diabetes among 594 global projects (JDCA 2020). Stem Cell Educator therapy is a single dialysis-like treatment that fundamentally “resets” a patient’s immune system and corrects the underlying autoimmunity. 200+ patients between the ages of 3 and 70 have been treated in 10 years of clinical research in Spain, China, and US. 70% of type 1 and type 2 diabetic patients demonstrated clinical efficacy. Many patients reduced insulin dosing and some have become insulin independent. This technology has been successfully tried in more than 10 autoimmune diseases including alopecia, lupus, fibrosis, and scleroderma. This therapy is ready to use and is approved to begin three FDA phase 2 clinical trials (type 1 diabetes, alopecia areata, COVID-19). Throne is looking to raise $5M to complete US FDA phase 2 through to commercialization. Throne is open to partnerships, joint ventures, investments, and license arrangements.

2nd Place – Praetego

Praetego is a pre-clinical stage pharmaceutical company with a mission to improve the health and longevity of diabetic patients. Praetego is developing novel small molecules (Amadorins) to alleviate serious diabetic complications, starting with peripheral neuropathy. Amadorins are first-in-class molecules able to inhibit a primary driver of diabetic microvascular disease and are derived from a clinically proven prototype.

3rd Place – Nano PharmaSolutions

A proprietary drug delivery nanotechnology that generates poorly soluble drugs as nanoparticles for better bioavailability. Our NanoTransformer(TM) technology can generate drug nanoparticles through phase transfer method without using any chemicals or solvent. We work with (1) preclinical stage drug developers for animal study formulations and (2) innovative generic companies for generic nanodrug development. We are at revenue stage and our revenue forecast is $150M in 2026 (our target exit time frame).

Congratulations to each of the winners, who have received free tickets to future RESI conferences to boost their fundraising efforts. Thank you to all finalists, judges, and attendees who make the IPC an exciting and powerful part of RESI! Interested in joining a future IPC? Applications are open for RESI Partnering Week September, featuring three separate RESI conferences! Select the logos below to learn more!

Apply for RESI IPC
Sept.13-15
Apply for RESI AI IPC
Sept.16-17
Apply for RESI Longevity IPC
Sept.16-17

Super early bird rates apply until July 9. Sign up now to save $100!

RESI Partnering Week Returns September 13-17

10 Jun

By Rory McCann, Marketing Manager & Conference Producer, LSN

RESI Partnering Week (RPW) returns September 13-17 for five days of match-based partnering, educational workshops, expert panels, innovative pitch sessions, and more!

RPW features a unique model made up of three days of Digital Redefining Early Stage Investments (RESI), followed by two days of targeted partnering and unique content designed specifically for age-tech and AI technology.

Get to know each event to see which are a fit for you! Super early bird rates are available until July 9, so register today to SAVE!

Redefining Early Stage Investments (RESI)

September 13-15, 2021

resi-sept-logoThe Redefining Early Stage Investments (RESI) conference series brings together startups with early-stage investors and strategic channel partners to maximize the capability of these companies, from seed to series B, to find partners who are a fit for their technology and stage of development. RESI is cross-border and cross-domain, connecting start-ups with ten categories of global investors across the silos of drugs, devices, diagnostics, and digital health. RESI caters to both the earliest stage startups, those seeking grants, seed and angel capital, and the early-stage firms who seek seed, series A, and B funding.

RESI AI

September 16-17, 2021

resi-ai-septArtificial intelligence (AI) is rapidly reshaping the healthcare landscape and redefining what is possible in life science. RESI AI is a digital partnering conference that connects the investors and strategic partners and matches them to companies developing and commercializing AI technology in drugs, devices, diagnostics, and digital health to revolutionize healthcare. RESI AI features investors and entrepreneurs sharing their experiences in early-stage funding and what makes a successful partnership. This two-day digital conference provides the opportunity to meet and learn from experts, build relationships, and advance healthcare through the power of AI.

RESI Longevity

Co-Organized with Mary Furlong & Associates
September 16-17, 2021

resi-longevity-septThe aging boomer population contributed $8.3 trillion in economic activity to the 2018 US economy, and that number is projected to triple by 2050. The need for advancements in drugs, devices, diagnostics, and digital health for the treatment of age-related conditions is crucial. RESI Longevity is a new partnering conference focused on conditions related to aging, market challenges, and solutions via early-stage companies and their promising tech and products. RESI Longevity brings fundraising startups together with investors in age-tech innovation to make deals in order that today’s seniors live longer, healthier lives.

Learn more about what to expect at each event and how you can get involved!

1:1 Partnering

handshack_icon

The investors attending RESI represent a huge pool of capital, and Life Science Nation (LSN)’s unique partnering system enables fundraising companies find the investors and strategic partners that are a best fit for their technology and stage of development.

  • Review profiles of other participants.
  • Schedule one-on-one and/or group meetings.
  • Build your customized conference schedule, from panels to presentations to partnering meetings

Investor Panels & Workshops

panels_icon_new

Panels and workshops highlight panelists who can provide their perspective on current trends, as well as valuable advice to fundraising start-ups. From big corporations to angel groups, and from established VCs to family offices, the panelists participating at RESI reflect LSN’s global investor network. Panels will be live-streamed, giving audience members a chance to get their questions answered in real-time.

Innovator’s Pitch Challenge

ipc_icon_new

The Innovator’s Pitch Challenge (IPC) is an opportunity for early-stage companies to gain additional exposure to conference attendees, pitch directly to a panel of relevant investors, and participate in a live Q&A session. Participating companies pay registration and a pitching fee to host their company materials on the Live Agenda and participate in the live pitch session.

Apply for RESI IPC
Sept.13-15
Apply for RESI AI IPC
Sept.16-17
Apply for RESI Longevity IPC
Sept.16-17

Virtual Exhibit Hall

exhibitor hall

Exhibitors and sponsors will be featured on a dedicated page with a virtual exhibitor booth, showcasing their services and the value they can provide. Participating tech hubs can highlight their programs and constituent companies.

Digital RESI June Innovator’s Pitch Challenge Finalists

27 May

By Claire Jeong, Chief Conference Officer, Vice President of Investor Research, Asia BD, LSN

claire

With the next Digital Redefining Early Stage Investments (RESI) conference taking place in less than two weeks, Life Science Nation (LSN) is pleased to announce the fifty companies presenting in the Digital RESI June’s Innovator’s Pitch Challenge (IPC).

The IPC’s unique format and approach to connecting startups to investors has made it a popular feature at Digital RESI, and the team has received a record number of applications from startups across the globe. These sessions are not only helpful for companies trying to increase their exposure in the life sciences community, but also for investors who are actively looking at early-stage innovations. Many have found IPC sessions a fun and productive way to engage with one another.

The ten sessions are divided based on sector and types of technologies, with each session featuring five companies and a panel of investor judges for live engagement and a Q&A segment. If you’re interested in seeing a live pitch session and connecting with investors who are a fit for your product and stage of development, there’s still time to register for Digital RESI June. Select a logo to learn more about each finalist company:

Innovator’s Pitch Challenge #1 (Oncology)
Tuesday, June 8, 11:00AM – 12:00PM EDT

 

Innovator’s Pitch Challenge #2 (Medical Devices)
Tuesday, June 8, 1:00PM – 2:00PM EDT

 

Innovator’s Pitch Challenge #3 (Digital Health)
Tuesday, June 8, 3:00PM – 4:00PM EDT

 

Innovator’s Pitch Challenge #4 (Diagnostics)
Tuesday, June 8, 5:00PM – 6:00PM EDT

 

Innovator’s Pitch Challenge #5 (Therapeutics)
Wednesday, June 9, 12:00PM – 1:00PM EDT

 

Innovator’s Pitch Challenge #6 (Novel Drug Delivery)
Wednesday, June 9, 3:00PM – 4:00PM EDT

 

Innovator’s Pitch Challenge #7 (Medical Devices & Diagnostics)
Wednesday, June 9 5:00PM – 6:00PM EDT

 

Innovator’s Pitch Challenge #8 (Therapeutics & Diagnostics)
Thursday, June 10, 12:00PM – 1:00PM EDT

 

Innovator’s Pitch Challenge #9 (Advanced Therapies)
Thursday, June 10, 3:00PM – 4:00PM EDT

 

Innovator’s Pitch Challenge #10 (Therapeutics)
Thursday, June 10, 4:00PM – 5:00PM EDT

Join These Investor Panelists at Digital RESI June

20 May

By Joey Wong, Investor Research Analyst, LSN

Digital Redefining Early Stage Investment (RESI) Conference, June 8-10, takes place in just a few weeks! The Life Science Nation (LSN) investor research team has been busy organizing six exciting panels focusing on different investor groups, from big pharma, corporate venture capital, to family offices and angel investors, etc. During these panels, active life science investors will share their insight and provide tactical advice on outreach, positioning, and building the right relationships to move products forward. The goal is to facilitate constructive conversations between investors and fundraising CEOs, and provide insights on how companies can raise capital and acquire partnerships effectively.

Another exciting part of the upcoming conference is the Innovator’s Pitch Challenge, where investors and industry experts are invited to participate in the live Q&A sessions to give feedback and ask questions to the pitching companies.

If you are interested in meeting these investor panelists and pitch judges, register here for Digital RESI June! Partnering is open, but there is still time to sign up!

For those who have already registered, we highly recommend you to join the panels that are relevant to your company; you can RSVP for any panels in the partnering system to block off your meeting schedule.

Here are some of the investors who will be joining our panels and pitch sessions at Digital RESI June:

Hamzeh Abdul-Hadi
Principal
Hikma Ventures
Brent Ahrens
General Partner
Canaan Partners
Faz Bashi
Member of BOD
Life Science Angels
Attila Bérces
Advisor
FastVentures
Brian Bronk
Head of External Innovation, Rare Diseases
Sanofi
Hannah Chang
Managing Director
Wu Capital
Elizabeth Cho-Fertikh
Co-Founder & Managing Director
Meda Angels
Chris Church
Associate Director, Search & Evaluation, CVRM
AstraZeneca
Juan Cueva
Senior Associate
Action Potential Venture Capital
Geoff Dacosta
Director, Business Development and Licensing
Medtronic
Ben Evans
Managing Director
InHealth Ventures
Naomi Fried
Managing Director & Co-Founder
Ambit Health Ventures
Robert Garber
Partner
7wire Ventures
Miles Gerson
Partner
Takeda Ventures
Sam Goldberger
Co-Founder & Managing Partner
Ambit Health Ventures
Sherry Grisewood
Senior Investment Officer
FoxHill Asset Management
Bryan Grulke
Partner
Volcano Capital
Eric Heinz
Director, Business Development (M&A)
Smith & Nephew
Merom Klein
Entrepreneur Mentor
Keiretsu Forum
Marc Martin-Casas
Seed Investments & Development
Illumina Accelerator
Andy Merken
Partner, Corporate and Securities Co-Chair, Life Sciences
Burns & Levinson
Brian Meshkin
Managing Partner, Profound Ventures Partner, Cancer Fund
Profound Ventures
Petra Meyer
Managing Director – HealthCare Sector Group Lead
Golden Seeds
Junaid Mian
Managing Partner & Longevity Lead
SP8CEVC
Nicholas Mourlas
Senior Director, New Ventures
Johnson & Johnson Innovation
Ashley Ng
Director
McKesson Ventures
John Parker
Founder & Managing Director
Springhood Ventures
Richard Proscia
Senior Associate
Providence Ventures
Meghana Rao
Senior Manager, New Venture Transactions
Johnson & Johnson Innovation
Nadav Shimoni
Head, Digital Health
Arkin Holdings Ltd
Yaniv Sneor
Founding Member
Mid Atlantic Bio Angels
Jill Sorensen
Chief Operating Officer
Medical Technology Enterprise Consortium (MTEC)
Eran Steinberg

 

Imaging Arts

Ben Sun
Investor/member
Sand Hill Angels
Anna Turetsky
Principal, Venture Investments
The Mark Foundation for Cancer Research (MFCR)
Thomas Vogelsong
Investor/Life Science Advisor
KYTO Technology and Life Science
 
Scott Weiner
Partner
Amzak Health
Tim Xiao
Principal
Delos Capital
John Yianni
Managing Partner
Earlybird
 

Don’t Miss Out on the Innovator’s Pitch Challenge (IPC) – Applications Due Tomorrow!

13 May

By Claire Jeong, Chief Conference Officer, Vice President of Investor Research, Asia BD, LSN

claire

Tomorrow is the last day to apply for the Innovator’s Pitch Challenge (IPC) at Digital Redefining Early Stage Investments (RESI), June 8-10. While IPC is a relatively new addition to our conferences, it has received overwhelmingly positive feedback from participating companies and investor judges alike. It is a great way for companies to boost their exposure among the life sciences community, especially to investors and strategic partners. For investors, the IPC serves as a fun and informative way to virtually engage with innovative companies. It is not a surprise that post-IPC follow-ups often lead to productive discussions for potential investment or strategic partnership.

We have received a record-breaking number of applications for this event and are quickly filling up to capacity. If you are interested in a unique, unparalleled opportunity to showcase your technology, please make sure to apply by tomorrow, Friday, May 14!

Preliminary IPC Finalists at Digital RESI

13 May

By Rory McCann, Marketing Manager & Conference Producer, LSN

Applications for the Digital Redefining Early Stage Investments (RESI) Innovator’s Pitch Challenge are due tomorrow, May 14. A record number of applications have been submitted and Life Science Nation’s expert team of researchers have been flooded with innovative technology coming to Digital RESI, June 8-10.

Check out the preliminary list of finalists for the Digital RESI June Innovator’s Pitch Challenge. There is still time to apply and confirm your spot before tomorrow’s deadline. Get yourself in front of investors in a few short weeks and add your company logo to the list!

Stories for a New Age

6 May

By Rory McCann, Marketing Manager & Conference Producer, LSN

When LifeBio Founder and CEO, Beth Sanders started telling stories, she knew how influential they could be. Today, patients and healthcare providers are using LifeBio’s storytelling platform to connect, decrease loneliness, and promote better care and overall wellness.

LifeBio was a winner at the March Innovator’s Pitch Challenge at Longevity, Health & Innovation (now RESI Longevity). Registration for RESI Longevity (September 16-17) is now open at super early bird rates until July 23, and applications for the next Innovator’s Pitch Challenge are open!

Listen to our conversation with Beth on the origin and mission of LifeBio, and how stories are having a strong impact on today’s seniors and the healthcare system.

%d bloggers like this: